• Users Online: 45
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 3  |  Issue : 2  |  Page : 31-35

Pharmacologic management of chronic heart failure

1 Division of Cardiology, Morehouse School of Medicine, Atlanta, GA, USA
2 Division of Cardiology, Morehouse School of Medicine; Heart Failure Program, Grady Health System, Atlanta, GA, USA

Correspondence Address:
Anekwe Onwuanyi
Division of Cardiology, Morehouse School of Medicine, Atlanta, GA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/njct.njct_1_19

Rights and Permissions

Heart failure (HF) is a complex progressive clinical syndrome that is associated with high morbidity and mortality. Although several pharmacologic therapy have become available for treatment of certain HF phenotypes, HF still is characterized by recurrent hospitalizations and need for advanced therapy resulting in huge economic burden. The optimal management of HF includes modifying risk factors, identifying and treating reversible causes, address socioeconomic barriers to care and instituting appropriate pharmacologic and device treatments. In this brief review, we summarize the pharmacologic treatment of chronic heart failure and highlight a few major landmark trials that provide the basis for specific therapy in clinical practice.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal